In the latest slap in the face to pro-lifers and women across the country, President Barack Obama’s Food and Drug Administration has expanded the use of chemical abortion drugs in the abortion industry.
Since the announcement Wednesday, Planned Parenthood has been celebrating its victory in the media. The decision means the abortion giant will be able to abort more babies at a later age with lower costs, while hiding the drug’s high risks to women.
The FDA decision expands the label use of the dangerous chemical abortion drug regimen RU-486 by allowing it to be administered up until 10 weeks of pregnancy instead of seven and by allowing smaller doses to be used. These expansions have been approved despite the FDA’s own studies showing RU-486 has high failure rates and risks to women’s health.
Planned Parenthood celebrated its victory in a press release, claiming that the decision was a “significant step for science, for women and for health care providers.”
“First and foremost, this is another affirmation from the FDA that medication abortion is a safe and effective option to end an early pregnancy,” said Raegan McDonald-Mosley, Chief Medical Officer of Planned Parenthood in a statement. “Studies show medication abortion has a 99 percent safety record, and that medication abortion is up to 98 percent effective in ending an early pregnancy.”
CLICK LIKE IF YOU’RE PRO-LIFE!
Abortion business CEO Cecile Richards also sent out this joyous tweet about the announcement:
Abortion care should be based on the best medicine & science – not politics. That’s why this update is so exciting. https://t.co/N02iWTobJh
— Cecile Richards (@CecileRichards) March 30, 2016
However, Planned Parenthood and the FDA ignored the science behind the abortion drug and the studies showing that it’s responsible for the deaths of at least 14 women in the U.S. and dozens more worldwide. In an April 2011 report, the FDA found that 2,207 women in the U.S. also were injured by the drug. A Planned Parenthood study also admits at least one woman is seriously injured from the abortion drug daily.
The clinical trial submitted to the FDA for approval explains why the FDA originally recommended the drug only up to seven weeks of pregnancy. The RU-486 regimen fails in 1 out of 12 women with pregnancies less than or equal to 49 days (seven weeks), according to the clinical trial. Those failures, however, increase to 1 out of every 6 women with pregnancies just one week advanced (50-56 days), and further still to nearly 1 out of every 4 pregnancies at 57-63 days gestational age. When using RU-486, 1 out of 100 women with pregnancies less than or equal to 49 days will require emergency surgery; however, this number increases dramatically to 1 out of every 11 women with pregnancies of 57-63 days gestational age.
Despite the risks, Planned Parenthood and other abortion facilities have been using the drugs off label for years, endangering women’s lives without their knowledge. McDonald-Mosley readily admitted the off-label usage in her statement, but she did so in a deceptive way that makes Planned Parenthood appear cutting-edge and progressive.
“Since Planned Parenthood’s medical standards are constantly-evolving with the latest clinical research findings, we have actually had the protocols approved today in place at Planned Parenthood for some time,” she said. “But given the restrictions on medication abortion enacted at the state level in recent years, updating the label to reflect best medical practice represents a significant step forward for science, for women, and for health care providers who want to give our patients the highest quality care.”
As McDonald-Mosley hints, one of the main reasons why Planned Parenthood is so happy about the FDA decision is because it basically nullifies a group of state laws that were meant to protect women from abortion clinics’ abusive off-label use of RU-486. The laws require abortion businesses to use the drug according to FDA standards; but now that the abortion lobby has succeeded in weakening those standards, women and unborn babies’ lives are in jeopardy again.
RU-486 has nearly claimed the lives of two million unborn children in the United States since its approval at the end of the Clinton administration.
After the announcement, Jeanne Mancini, President of the March for Life Education & Defense Fund, explained what the decision means for women and unborn babies.
“Today the Food and Drug Administration put access to abortion over and above women’s health by extending the use of chemical abortion to two months,” Mancini said. “RU-486 (chemical abortion) is harder on women physically and involves less medical oversight than surgical abortion. The March for Life calls on the FDA to release the latest adverse events reports related to RU-486, showing the number of complications and deaths related to this drug that was approved in a rushed, politicized fashion back in 2000.”